A 2024 comprehensive review (1) by Gary Williamson and others, challenges conventional wisdom in nutritional biochemistry by reevaluating how polyphenols—widely celebrated for their health benefits—function within the human body. While traditional research has largely focused on the unmetabolized polyphenols, this analysis reveals a previously underappreciated complexity: most dietary polyphenols undergo extensive phase II metabolism in the human body, transforming into conjugated forms (primarily glucuronides and sulfates) that dominate human circulation. These transformations appear to be highly bioactive and relevant for systemic human health rather than elimination products from detoxification processes as was commonly thought.

Drawing on rigorous human pharmacokinetic trials from Harvard and other leading research institutions, the authors question the relevance of countless in vitro studies using parent polyphenol compounds rarely found in meaningful concentrations in vivo. This review establishes a new framework for understanding polyphenol bioactivity based on actual circulating metabolites rather than their precursors by systematically tracking which phenolic acid metabolites appear in blood and urine after polyphenol consumption. Many parent polyphenols (like quercetin, resveratrol, curcumin, and EGCG) show strong in vitro activity, often at non-physiological concentrations.

But in vivo, these compounds are extensively metabolized, usually within minutes, into microbial catabolites or phase II conjugates (e.g., sulfates, glucuronides). Scientists previously thought that these conjugates were forms that the body wanted to discard as part of the detoxification process —turns out it's those forms that actually bioactively circulate in our blood and tissues providing systemic health benefits.

While most of the parent compounds themselves (who often make news headlines from in vitro results) don’t even appear in plasma (or do so transiently, at nanomolar levels).

Phenolic compounds synthesized via the shikimic acid and polyketide pathways, commonly known as polyphenols, are bioactive molecules abundant in plant species. Structurally, they consist of one or more aromatic rings bearing one or more hydroxyl groups. These compounds fall into several groups, including flavonoids, non-flavonoids, and tannins, with more than 8,000 identified types encompassing phenolic acids, lignans, and stilbenes.

Polyphenols have notoriously low absorption rates in the small intestine, a substantial portion reaches the colon intact or as partially metabolized derivatives. Unabsorbed polyphenols act as prebiotics, shaping microbial communities, and promoting the growth of beneficial bacteria like Bifidobacterium and Lactobacillus that produce bioactive metabolites (e.g., short-chain fatty acids).

The microbiota-derived metabolites (like equol from isoflavones or urolithins from ellagitannins) often exhibit stronger biological activities than parent compounds. Regular polyphenol consumption can reshape microbiome composition toward more favorable profiles associated with improved metabolic health, reduced inflammation, and enhanced gut barrier function.

Even low systemic concentrations (nM–µM) of polyphenol metabolites, may suffice to modulate cellular pathways (e.g., kinase inhibition) through threshold effects. Cumulative exposure through regular and chronic intake leads to sustained levels, potentiating long-term benefits (e.g., cardiovascular protection). Polyphenols may also enhance the activity of other dietary compounds through synergies (e.g., vitamins, and fiber).

✅Cumulative exposure through regular and chronic intake leads to sustained systemic polyphenol metabolite levels and microbiome adaptations

Polyphenols exert potent and multifaceted effects on vascular health. Once ingested, certain polyphenols—undergo metabolism in the small intestine and liver to form phase II conjugates (e.g., sulfates and glucuronides), which enter circulation and exert biological activity at low micromolar concentrations. These conjugates can improve endothelial function by enhancing nitric oxide (NO) production, reducing endothelin-1 levels, and lowering vascular oxidative stress. In parallel, unabsorbed polyphenols and larger oligomers reach the colon, where they are fermented by the gut microbiota into smaller, highly bioactive metabolites like phenyl-γ-valerolactones and hydroxycinnamic acids, which have been shown to further support endothelial function, reduce vascular inflammation, and promote vasorelaxation through mechanisms involving AMPK and cGMP signaling. Specific microbial metabolites—such as dihydrocaffeic acid (DHCA), dihydroferulic acid (DHFA), and ferulic acid-4′-sulfate—have demonstrated endothelial benefits. These effects collectively contribute to improved flow-mediated dilation (FMD), reduced arterial stiffness, and lower blood pressure.

Many phenolic acids and their metabolites have anti-inflammatory properties. They can interfere with the pathways that produce inflammatory cytokines. For instance, several of these compounds inhibit NF-κB, a protein complex that acts like a master switch for inflammation, thereby reducing cells’ output of IL-6, TNF-α, and other cytokines. Some boost our antioxidant defenses or trigger the release of beneficial signaling molecules in blood vessels. What’s truly striking is the potency observed in lab studies: certain phenolic acid metabolites begin to show effects at micromolar concentrations (around 0.1–1.0 µM), which is a level that can be achieved in the body with a polyphenol-rich diet​

Their actions involve scavenging free radicals, chelating metal ions, regenerating antioxidants like vitamin E, and modulating critical signaling cascades including NF-κB and MAPK. Indirectly, these compounds activate the Nuclear Factor Erythroid 2-related Factor 2 (NRF2) pathway, a pivotal defense mechanism against oxidative stress. Under normal conditions, NRF2 is sequestered by Keap1 and targeted for degradation; however, polyphenols or their electrophilic metabolites modify cysteine residues on Keap1. This modification stabilizes NRF2, enabling its translocation to the nucleus where it binds to antioxidant response elements and triggers the expression of enzymes such as heme oxygenase-1, glutathione S-transferase, and NADP(H)-quinone oxidoreductase 1.

The scientific community has long celebrated polyphenols—compounds abundant in fruits, vegetables, tea, wine, and chocolate—for their potential health benefits. However, a disconnect exists between laboratory research and human physiology that may undermine many of our assumptions about how these compounds work.

Regardless of their original class (flavonoids, phenolic acids, stilbenes, or lignans), most polyphenols undergo extensive transformation within the human body. When consumed, these compounds encounter multiple metabolic processes. Phase II metabolism in the liver rapidly conjugates polyphenols with glucuronic acid or sulfate groups, while gut microbiota can break down the complex ring structures of flavonoids into simpler phenolic acids. This extensive metabolism means that the original compounds studied in laboratory settings rarely reach target tissues in their unmodified forms.

What circulates in human blood after polyphenol consumption is predominantly a collection of metabolites—conjugated forms and breakdown products—rather than the parent compounds. For instance, when we consume quercetin from onions or catechins from green tea, what appears in our bloodstream are primarily glucuronide and sulfate conjugates, along with various phenolic acids resulting from the breakdown of their characteristic ring structures. These metabolites often have completely different chemical properties, bioavailability, and potentially different biological activities compared to their precursors.

This revelation has implications for polyphenol research. Countless in vitro studies have used unmetabolized compounds at concentrations unlikely to be achieved in vivo, potentially leading to misleading conclusions about mechanisms of action (f.e. the popular claims that resveratrol or quercetin are “anti-aging substances”). Moving forward, researchers need to focus on the actual molecules present in human circulation—the conjugated forms and breakdown products. Understanding this metabolic fate of polyphenols represents a paradigm shift that could redirect nutritional research toward more physiologically relevant approaches and ultimately provide more accurate insights into how these dietary components influence human health.

Phenolic acids are the simplest phenolic compounds that are commonly found in plants. Generally, they can be classified into two broad categories based on their chemical nature: benzoic acid derivatives (hydroxybenzoic acids with C6-C1 structure) and cinnamic acid derivatives (hydroxycinnamic acids with C6-C3 structure).

As the simplest phenol compounds, phenolic acids can be either preformed as direct dietary components or byproducts coming from our metabolism, either through the microbiome gut metabolism of polyphenols or through our endogenous enzymatic reactions to ingested dietary polyphenols. They are also created by endogenous processes like amino acid and neurotransmitter (tyrosine, dopamine) metabolism.

The particular significance of phenolic acids in human health research lies in their bioavailability profile. After consuming flavonoid-rich foods, the blood levels of resulting phenolic acids can exceed those of the original compounds by orders of magnitude.

What’s particularly interesting is that the body changes these compounds—attaching things like sulfate or glucuronic acid to them—but these altered versions still work. In some cases, they’re even more effective than the original compounds. For a long time, the assumption was that once these compounds were conjugated—turned into sulfates or glucuronides—they were being prepared for elimination and had little to no activity. However, studies now show that these conjugated forms often maintain biological effects. In some cases, they even outperform their original compounds. One example is dihydrocaffeic acid-3′-sulfate, which can reduce inflammatory cytokine production in blood vessel cells at just a tenth of a micromole per liter. This challenges the old view that conjugation is a detox mechanism. Once these compounds are in circulation, they show activity across different systems in the body.

In the vascular system, —sometimes just a micromole per liter or less of phenolic acids—can help reduce inflammation in blood vessels and support healthy endothelial function. In studies on people, certain forms have been linked to better blood flow, which is a good sign for heart and circulatory health. In the colon, they’re present in much higher amounts and seem to reduce inflammation in colon cells, hinting at a possible protective effect against gut issues. There’s also growing evidence that some of them may help the brain by lowering levels of harmful proteins tied to diseases like Alzheimer’s. Certain C6–C5 metabolites, such as specific valerolactones from cacao consumption, can interfere with the formation of amyloid-beta peptides—key players in the development of Alzheimer’s disease.

Phenolic acids like caffeic acid, ferulic acid, and benzoic acid derivatives exhibit bactericidal effects by disrupting microbial cell membranes and acidifying cytoplasm. Studies show they prevent resistance development in multidrug-resistant (MDR) pathogens like MRSA and sensitize bacteria to antibiotics. Kardelen Ecevit et al., published in Future Pharmacology (2022), provides a comprehensive review of the antimicrobial potential of natural phenolic compounds as alternatives to conventional antibiotics.

Polyphenols are studied extensively for their potential health effects, yet a persistent gap exists between in vitro data and clinical outcomes. Laboratory experiments frequently use concentrations that far exceed what is physiologically achievable—curcumin, for instance, inhibits COX-2 at over 50 μM, a dose not reflected in human plasma following typical consumption. On top of that, polyphenols are antioxidants themselves, once whole foods lose their entourage effect, our body might no longer know what to do with the isolated forms. Even widely researched compounds such as epigallocatechin-3-gallate (EGCG) from green tea, known for antioxidant and anti-inflammatory properties, can exhibit prooxidant effects or even liver damage as an isolated supplement or when consumed at high doses as noted by Professor Barry Halliwell.

Flavocoxid was a medical food used for osteoarthritis, withdrawn by the FDA in December 2017 due to reports of liver toxicity, including acute liver injury. Flavocoxid consists of isolated individual polyphenols, specifically baicalin, and catechin, which are purified from plants like Scutellaria baicalensis and Acacia catechu, rather than being a broad extract of high polyphenol foods. Another well-known popular isolated polyphenol supplement is “Mitopure”, which has isolated Urolithin A.

Polyphenols exist across a continuum—from individual compounds to complex food matrices—that strongly influences their bioavailability, activity, and physiological effects. At one end of this spectrum are pharmaceutical-grade preparations of single molecules such as resveratrol, quercetin, or EGCG. These allow for precise dosing in experimental settings but often yield disappointing results in clinical trials. Without the presence of synergistic compounds that aid absorption or modulate activity, isolated polyphenols follow different pharmacokinetics and may show limited efficacy. For example, resveratrol’s performance is markedly improved when delivered as part of a red wine extract, which includes other phytochemicals that enhance its absorption. As discussed previously, parent compounds also never reach in vitro levels due to the generation of phenolic acids by our body and microbiome. These findings argue for dietary sources over isolated supplementation.

In the middle of this spectrum lie food polyphenol extracts. These are concentrated preparations derived from natural sources like grape seeds, green tea leaves, or blueberries, retaining much of the polyphenol diversity while removing non-essential components such as water and fiber. Extracts offer a practical way to deliver higher polyphenol doses than whole foods alone, while still preserving some of the natural compound interactions that support bioavailability and efficacy. Processing can also help break down barriers within the food matrix that limit absorption. In both clinical and research settings, these extracts provide a balance of potency and complexity. A meta-analysis by T. Kiyimba and colleagues found that purified (whole) food extracts had advantages for lipid metabolism and waist circumference, while whole food sources themselves, were more effective at lowering blood pressure—likely due to the broader synergy between polyphenols and other nutrients. Combining both forms may offer complementary benefits in addressing conditions such as hypertension and dyslipidemia.

✅ whole food polyphenols and/with whole food-based polyphenol extracts are both safe and effective

🚫 isolated individual polyphenols are not safe and ineffective

Phenolic acid metabolites often coexist in plasma, potentially offering cumulative anti-inflammatory benefits despite individual concentrations being below traditional therapeutic thresholds. Research suggests that sustained intake of polyphenol-rich foods and beverages may amplify health benefits through additive or synergistic mechanisms, particularly for inflammation regulation and vascular function improvement.

The metabolism of dietary polyphenols demonstrates nonlinear effects that influence their bioavailability and efficacy. Most polyphenols undergo rapid metabolism in the small intestine and liver through sulfation, glucuronidation, and methylation—processes dependent on finite enzymatic capacities that can become saturated at higher intake levels. This saturation creates a nonlinear relationship between intake and bioavailability, where increasing consumption beyond certain thresholds yields diminishing returns or shifts metabolite profiles. Rather than focusing on large, sporadic doses, optimal benefits may be achieved through moderate, regular intake patterns that maintain effective metabolite levels while accommodating the body's enzymatic and microbial processing rhythms. This principle of "long-term, diversified, modest, rhythmic exposures" appears applicable across most polyphenols with similar metabolic fates.

✅ The sustained intake of coexisting phenolic acids offers cumulative nonlinear effects, optimal dosing requires moderate but regular intake patterns.

I will include some phenolic acids that are not part of the most potent ones, but might serve certain functions nonetheless or fill certain gaps. I have marked these with a 🟡

While this part might appear to be about coffee, it’s merely summarising some of the most potent phenolic acids for health noted in the study, and while present in other foods, these C6-C3 metabolites just so happen to be the highest in coffee.

The key players here are preformed caffeic acid, ferulic acid, and their downstream microbial metabolites: dihydrocaffeic acid (DHCA) and dihydroferulic acid (DHFA). Caffeic acid is metabolized into DHCA by losing the double bond in its side chain. Ferulic acid is metabolized into DHFA through a similar saturation of its side chain double bond. These small molecules are not only present in trace amounts in certain foods but are predominantly formed through the metabolism of chlorogenic acids (CGAs), a major class of polyphenols richly supplied by coffee.

Caffeic acid and ferulic acid appear in the bloodstream mainly as their phase-2 conjugates – sulfates and glucuronides – within an hour of coffee consumption. These conjugates, particularly the 3′-sulfate of caffeic acid and 4′-sulfate of ferulic acid, are not inert: they exhibit biological activity at concentrations as low as 0.1 μM. Studies show that they enhance nitric oxide (NO) availability, lower endothelin-1, and reduce oxidative stress in endothelial cells. These early-phase compounds may be responsible for some of the acute vascular effects observed after coffee intake, such as improved flow-mediated dilation (FMD).

Later, as undigested chlorogenic acids reach the colon, gut microbes convert them into smaller, more stable phenolic acids: notably DHCA and DHFA. These microbial metabolites have been detected in human plasma several hours after intake and can remain elevated for extended periods. DHCA, in particular, has been shown to reduce IL-6, VCAM-1, and monocyte adhesion in vascular endothelium at concentrations well within the physiological range (0.1–0.3 μM). One of the few phenylpropanoic acids showing effects below 1 μmol/L, particularly in endothelial and adipocyte models. Boosts eNOS in endothelial cells. At 1 µM, it significantly reduced inflammatory signals – cutting down TNF-α and IL-6 release from activated macrophages, along with lowering oxidative stress markers, effective at fighting inflammation and infection. DHFA similarly contributes to anti-inflammatory and endothelial-protective pathways. It has been observed to activate Nrf2-related pathways (boosting antioxidant response) and may inhibit inflammatory signaling cascades.

Ferulic acid-4′-sulfate (a phase-2 conjugation of ferulic acid) deserves special attention. It has been identified as an extremely potent vasorelaxant effect at 0.1 μmol/L, acting through the activation of soluble guanylate cyclase in vascular smooth muscle. In animal models, it lowers blood pressure when infused at concentrations as low as 0.1 μM. This kind of activity from a circulating dietary metabolite underscores the real functional potential of these compounds.

In clinical settings, elevated levels of these metabolites following coffee intake have been statistically associated with improvements in endothelial function, suggesting that they are more than correlated – they are likely contributors to vascular health.

Coffee stands out as nature's most efficient delivery system for key phenolic acids (caffeic, ferulic, and chlorogenic acids), offering a unique dual-phase release mechanism that provides both immediate and extended metabolic benefits. What makes coffee unique isn't just its chlorogenic acid content, but the fact that a single serving yields both fast-acting conjugates (within 1 hour) and slow-phase microbial metabolites (4–8 hours later), offering continuous metabolic activity across the day. While regular coffee provides substantial amounts of these compounds, green (unroasted) coffee beans contain even higher concentrations, making them an ideal complement to maximize these beneficial compounds.

Research suggests a metabolic threshold of approximately 1000 mg/day for chlorogenic acid efficiency, beyond which enzymatic saturation occurs—particularly affecting sulfotransferases. This saturation shifts metabolite balance away from more bioactive sulfate conjugates toward less effective glucuronides and unmetabolized compounds. With an average cup of coffee containing 70-350 mg of chlorogenic acid, just 3-4 cups daily may approach this ceiling.

Rather than being wasted, excess phenolics reroute to the gut microbiota, where they're converted to beneficial compounds like DHCA that re-enter circulation more slowly. The body processes phenolic acids similarly regardless of source—whether from coffee, berries, wine, or kale—as many larger polyphenols (flavonoids, anthocyanins, hesperidin) break down into the same core structures. While a polyphenol-rich diet can amplify coffee's effects, coffee remains the most direct and reliable foundation due to its immediate bioavailability compared to other sources that depend on gut microbiota conversion. By spacing out coffee intake throughout the day, it's possible to maintain steady levels of potent vascular metabolites, aligning with the body's metabolic rhythms while optimizing conjugation patterns and supporting microbiome health.

✅ By following a spaced-out intake pattern of regular brewed coffee together with a green coffee extract supplement, it’s possible to maintain a steady presence of the most potent vascular metabolites throughout the day. This strategy aligns with the body's metabolic rhythms, optimizes conjugation patterns, and even benefits the microbiome when thresholds are reached

✅ As a daytime pre-workout supplement take a green coffee extract 1 hour before exercise

✅ Consuming whole wheat or wheat bran or dark chocolate delivers ferulic acid right from the start and, because it’s bound to fiber, ensures it travels to the colon where gut bacteria can transform it into dihydroferulic acid (DHFA). On the other hand, brewed coffee offers a faster, more direct absorption pathway, primarily producing phase-2 conjugates of ferulic acid instead. Similarly, chokeberries and Ceylon cinnamon provide high amounts of fiber-bound caffeic acid.

C6–C1 metabolites like protocatechuic and vanillic acids are common breakdown products of polyphenols (e.g., flavan-3-ols, lignins). Their bioactivity (e.g., antioxidant, anti-inflammatory) contributes to the health benefits of plant-rich diets, despite their simpler structure compared to C6–C3 precursors.

Anthocyanins (flavonoid pigments in purple, and red produce)—particularly those based on cyanidin—are broken down in the body into both phloroglucinaldehyde (PGA) and protocatechuic acid (PCA) during digestion and microbial metabolism. This is a result of cleavage of the anthocyanin's flavonoid backbone, which contains two aromatic rings (A and B) and a heterocyclic C-ring connecting them.

Protocatechuic acid (PCA), or 3,4-dihydroxybenzoic acid, is a simple C6–C1 phenolic acid that represents a common metabolic endpoint of various dietary and endogenous pathways. It is formed primarily through gut microbial degradation of polyphenols, especially from cyanidin-based anthocyanins, but also from flavan-3-ols, flavonols, and to some extent lignin-derived compounds.

Unlike many phenolic acids, PCA also exists in its preformed form in select plant foods. Among these, green and red chicory stand out as particularly rich sources. Although such foods are not widely consumed in large quantities, PCA still appears consistently in human plasma. In the EPIC cohort, median circulating levels were measured at 178 nmol/L, making it one of the most abundant phenolic acids detected.

In addition to its dietary and microbial origins, PCA is also produced at baseline levels via endogenous metabolism—specifically from the breakdown of catecholamines like dopamine, norepinephrine, and epinephrine, which are synthesized from tyrosine. However, the study data indicate that dietary intake—particularly of anthocyanin-rich foods—has a far greater impact on circulating PCA levels than the low-level contributions from catecholamine turnover.

Dietary intake of anthocyanins or PCA-rich foods can raise plasma concentrations substantially—up to 400–500 nmol/L in some studies (e.g. after blood orange juice). This highlights PCA’s role as a dominant catabolite, but also as a directly ingestible compound, capable of contributing to systemic antioxidant, anti-inflammatory, and neuroprotective effects even without precursor breakdown.

PCA's mechanisms of action are diverse. As a dihydroxybenzoic acid, it's a direct antioxidant, scavenging free radicals and chelating metals; notably, the surge of PCA after anthocyanin intake correlates with increased plasma antioxidant capacity. But PCA is not just an antioxidant – it also acts on cell signaling and gene expression. It has shown anti-inflammatory and anti-proliferative effects at achievable concentrations. For example, in a colon cancer mouse model, PCA supplementation reduced tumor number and lowered inflammatory mediators like COX-2 and PGE₂. In neuronal cultures, PCA provided neuroprotection against β-amyloid toxicity, reducing ROS levels and abnormal autophagy in hippocampal neurons.

These findings suggest PCA targets pathways involved in neuroinflammation, apoptosis, and oxidative stress – making it a key complement for neuroprotection and anti-cancer support. PCA likely acts in many tissues (given its small size and polarity, it circulates freely and is excreted in urine), but it may concentrate in or strongly affect the bloodstream and endothelium (improving antioxidant status in plasma, protecting LDL, etc.) and the brain (crossing the blood-brain barrier in small amounts to exert antioxidative effects). To obtain PCA indirectly, one should consume anthocyanin-rich fruits and vegetables. Berries are prime sources and blood oranges provide cyanidin-based pigments that yield PCA during digestion. Even pigmented grains or tubers (black rice, purple sweet potato, red cabbage) contribute.

In 2019, Zheng et al (2). investigated the pharmacokinetics (absorption, metabolism, and excretion) of preformed PCA. Giving participants 150 grams of chicory, peak serum concentrations of free PCA reached 3,273 nmol/L at 1 hour post-consumption. PCA from chicory is bioavailable in humans and undergoes significant phase II metabolism (glucuronidation and sulfation). Its peak serum levels exceed thresholds shown to exert health benefits (e.g., anti-atherosclerosis) in preclinical studies, suggesting potential health-promoting effects with regular consumption.

✅ 50-150 grams of chicory is enough to reach thresholds exerting the health effects of PCA

A 2025 pilot trial (Mao, et al.)(3) adds to this. Researchers investigated the effects of chicory (Cichorium intybus L. var. foliosum), a leafy vegetable rich in phenolic acids such as protocatechuic, on endurance performance and recovery. Over a 7-day intervention, untrained college students consumed 100 g of Brussels chicory juice daily. When tested using a high-intensity aerobic protocol, those who consumed the chicory showed increased time to exhaustion—by 8–12%—and improved post-exercise recovery, marked by significantly lower blood lactate levels.

Mechanistically, the study pinpointed a novel role for phenolic acids in enhancing lactate oxidation. Rather than altering lactate production, the active compounds increased the localization of lactate dehydrogenase B (LDHB) to mitochondria in muscle cells, accelerating the conversion of lactate to pyruvate for aerobic metabolism. This shift was dependent on the mitochondrial cofactor CD147 and did not involve changes in LDHB gene expression—suggesting a targeted redistribution mechanism. This study is among the first to connect a phenolic-acid-rich vegetable with measurable improvements in human exercise performance and post-exercise lactate clearance, supporting the idea that specific polyphenols may influence energy metabolism beyond their antioxidant roles.

✅ Consuming 100 grams of chicory daily for 7 days and 90 minutes before exercise is enough to lower blood lactate levels during exercise, it increases high-intensity time to exhaustion and improves post-exercise recovery

✅ Anthocyanidin-rich foods such as Haskap berries, chokeberries, blackcurrants, blood oranges, and black rice are top tier. Red raspberries and purple carrots are moderate tiers.

✅ Direct PCA sources are red/green chicory, plums, and prunes, hibiscus tea is both a direct contributor and moderately rich in anthocyanins.

After consuming anthocyanin-rich foods, the catabolite phloroglucinaldehyde (PGA), or 2,4,6-trihydroxybenzaldehyde appears briefly in human plasma and urine, often at low concentrations, before being oxidized or conjugated. This benzenetriol aldehyde acts as a potent antioxidant, thanks to its three hydroxyl groups, which allow it to neutralize reactive oxygen species (ROS). Though less studied, PGA may also interact with proteins by forming adducts with amino groups, potentially influencing enzymatic or signaling pathways. Alongside other anthocyanin catabolites, PGA contributes to the protective effects of these pigments, reducing oxidative stress and inflammation in vascular and metabolic systems.

The benefits of anthocyanin catabolites like PGA are particularly notable in microvascular health. Research shows that metabolites from berry consumption—including PGA and dihydroxyphenylvalerolactones—lower ROS levels and suppress inflammatory pathways like NF-κB in cells. This translates to stronger capillaries and better blood flow in small vessels, which is crucial for organs with dense microvasculature, such as the eyes and kidneys. In the retina, these compounds may underlie the historical use of bilberries for improved night vision and their role in slowing diabetic retinopathy by shielding delicate vessels from oxidative damage. Similarly, emerging evidence suggests PGA and related catabolites could protect kidney glomeruli from oxidative injury, supporting overall capillary function across the body.

To tap into these benefits, a diet rich in anthocyanin-containing foods is key. Dark berries—think blueberries, blackcurrants, blackberries, elderberries, and cranberries—lead the pack, joined by cherries, pomegranates, red cabbage, purple carrots, purple sweet potatoes, and even red wine. Once consumed, anthocyanins break down into PGA and phenolic acids (like vanillic, gallic, and syringic acids) in the gut, which are then absorbed and circulated. A diverse intake of these blue-purple plant foods ensures a steady supply of catabolites, bolstering antioxidant defenses, curbing neuroinflammation, and reinforcing microvascular integrity in ways that intact anthocyanins alone might not achieve.

Anthocyanin polyphenols, together with procyanidins, suppress cartilage-degrading enzymes (e.g., MMP-13) and preserve proteoglycan content. Their antioxidant actions stabilize joint ECM, while also improving subchondral bone quality in degenerative models.

✅ Same anthocyanin tier list as PCA

Vanillic acid, or 4-hydroxy-3-methoxybenzoic acid, is a simple phenolic acid with a C6–C1 structure, widely present in plant-based foods. This benzoic acid derivative appears in small amounts in vanilla pods, fermented drinks like wine and beer, whole grains, olives, and artichokes. Beyond its natural occurrence, vanillic acid also forms in the body as a metabolite, arising from the breakdown of larger polyphenols such as ferulic acid (through β-oxidation), vanillin from vanilla, or even certain flavonoids like the anthocyanin peonidin. When we consume these precursors, vanillic acid enters the bloodstream at low levels—typically sub-micromolar (around 0.1 μM on average), though it can briefly peak in the low micromolar range. Though its concentrations are modest, this compound packs a punch with its antioxidant and anti-inflammatory properties.

Studies show that even tiny doses of vanillic acid, as low as 0.1 μM, can make a difference in cell cultures. For example, it reduces inflammation by curbing the production of IL-6 and the adhesion molecule VCAM-1 in activated endothelial cells, suggesting a protective role for the vascular endothelium. This ability to dampen inflammatory signals could help shield blood vessels from damage linked to oxidative stress or chronic inflammation. What’s more, vanillic acid can cross the blood-brain barrier—its presence in cerebrospinal fluid confirms it reaches the brain—hinting at neuroprotective potential. In neural cells, its antioxidant activity may combat oxidative stress and inflammation, offering a line of defense against brain-related damage.

By influencing multiple systems—the brain, blood vessel linings, and immune cells like macrophages—vanillic acid likely contributes to the broader health benefits of polyphenol-rich diets and vanillin-containing foods. Its subtle but widespread presence in plant sources, combined with its metabolic origins from other polyphenols, makes it a quiet yet significant player in supporting vascular and neurological health.

✅ While it's not a conventional dietary food, the dried root of Angelica sinensis contains high concentrations of vanillic acid—likely among the highest measured in any plant material.

✅ Downstream metabolite of Anthocyanins (with methoxy groups) such as purple corn (extremely high peonidin content), red and black rice, red grapes, and red wine. Purple sweet potatoes and blueberries are mid-tier.

✅ Fermented red wine vinegar or balsamic vinegar is another concentrated preformed source. This vinegar can contain up to 20–30 mg/L of free vanillic acid, depending on the grape variety, fermentation method, and oak aging. A small serving (1–2 tablespoons) of high-quality aged vinegar could supply a meaningful dose of vanillic acid, especially when consumed regularly.

Hippuric acid forms when our body attaches glycine to benzoic acid in the liver, emerging as a major end-product of dietary polyphenol metabolism. Unlike direct phenolic acids, hippuric acid serves as the final metabolite for many plant compounds and appears abundantly in urine after consuming fruits and vegetables. Once dismissed as merely waste, research now reveals hippuric acid offers meaningful anti-inflammatory benefits, particularly in the digestive system. It may also suppress inflammation by inhibiting NF-κB signaling and combat oxidative stress through antioxidant properties and metal ion chelation.

Studies show hippuric acid can alleviate inflammatory colitis in animal models, reducing disease severity, decreasing pro-inflammatory cytokines, and improving intestinal barrier integrity. It positively modulates gut microbiota—increasing beneficial bacteria while decreasing harmful species—and may directly influence inflammatory signaling by inhibiting NF-κB activation in colon cells when present at sufficient concentrations. Its metal-chelating ability and antioxidant properties further help reduce inflammation-fueling oxidative stress.

In healthy individuals, fasting plasma levels typically range from 1-10 µM, increasing after meals, especially with high-polyphenol diets. The most dramatic rise occurs in urine, where concentrations can reach thousands of micromolar over 24 hours, making it a valuable biomarker of fruit and vegetable consumption.

Importantly, when we consume large quantities of polyphenols that saturate our primary conjugation pathways (sulfation and glucuronidation), the body increasingly relies on hippuric acid formation as an overflow mechanism. This explains why mega-doses of polyphenol supplements might primarily produce additional hippuric acid for excretion rather than increasing active phenolics in the bloodstream—sometimes disproportionately, though it remains benign at physiological levels.

Diet type matters: high-protein diets produce less hippurate due to lower polyphenol content and glycine competition, while plant-rich diets markedly increase it. Thus, a polyphenol-rich diet doesn’t just supply antioxidants—it fuels a metabolic shift that elevates hippuric acid, potentially enhancing its protective effects.

One such compound, 5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone (DHPV), stands out as a remarkable microbial metabolite derived from flavan-3-ols—specifically catechins and procyanidins found in foods like green tea, cocoa, grape seeds, and apples. Belonging to the unique phenyl-γ-valerolactone class of C6–C5 ring metabolites, DHPV is emerging as a potent player in cellular health, offering antioxidant and anti-inflammatory benefits that extend far beyond its humble origins.

DHPV, characterized by its 3′,4′-dihydroxy (catechol) structure, is the dominant phenyl-γ-valerolactone produced by gut flora during the breakdown of flavanol-rich foods. This catechol backbone grants DHPV direct antioxidant capabilities, enabling it to neutralize free radicals. However, its true strength lies in its ability to influence cellular processes at remarkably low concentrations, making it a standout among microbial metabolites.

Some studies have shown that DHPV protects neurons from β-amyloid-induced damage at nanomolar concentrations, highlighting its unique neuromodulatory and antioxidant properties. This is unusually potent for a polyphenol-derived metabolite and supports the idea that DHPV's mechanisms go beyond radical scavenging, involving cellular signaling pathways (e.g. NF-κB inhibition, metal chelation, or modulation of mitochondrial function).

One of DHPV’s most impressive feats is its inhibition of matrix metalloproteinases (MMPs), enzymes activated by oxidative stress that degrade structural proteins like collagen. Studies have shown that DHPV blocks the activity of collagen-degrading MMP-1 and MMP-2 with an IC₅₀ (half-maximal inhibitory concentration) of approximately 0.11 μM. In human skin fibroblasts, the (4S)-DHPV enantiomer, at a mere 1 μM, reduced UV-induced MMP-1 expression by 50%, offering protection against photo-oxidative damage to collagen. This suggests that DHPV could play a role in preserving skin integrity and combating the effects of aging or UV exposure.

Beyond its antioxidant prowess, DHPV exerts powerful anti-inflammatory effects by targeting the NF-κB signaling pathway—a key driver of inflammation. In vascular cells exposed to pro-oxidative conditions, low micromolar concentrations of DHPV downregulated the expression of adhesion molecules like VCAM-1 and MCP-1, while also inhibiting IκB kinase activation. This cascade of effects reduced monocyte adhesion to endothelial cells, a critical step in the development of atherosclerosis and other inflammatory vascular conditions. By mitigating oxidative inflammation and tissue degradation, DHPV contributes to a net antioxidant benefit that could support cardiovascular health.

The journey of DHPV begins with the consumption of flavanol-rich foods. After ingestion, catechins and procyanidins from green tea, black tea, cocoa (think dark chocolate), red wine, or procyanidin-rich extracts (like grape seed or apple peels) are fermented by gut microbes into phenyl-γ-valerolactones, including DHPV. In the bloodstream, these metabolites primarily circulate as phase II conjugates (e.g., sulfated or glucuronidated forms), reaching peak plasma concentrations (Cmax) of 0.2–0.7 μM after a flavanol-rich meal. Free DHPV, the unconjugated aglycone, appears at much lower levels, with a Cmax often below 0.05 μM.

Despite these modest plasma concentrations, repeated consumption of catechin-rich foods can sustain a steady background level of these metabolites. Some studies report baseline “washout” levels of total phenyl-γ-valerolactones ranging from 1–3 μM in individuals with consistent flavanol intake. This persistence suggests that DHPV and its conjugates could accumulate over time, providing a continuous low-level influence on cellular health.

What makes DHPV particularly fascinating is its potency at low concentrations. Cellular studies demonstrate significant antioxidant and anti-inflammatory effects at 0.1–1 μM—levels that align with the conjugated forms circulating in plasma. While free DHPV levels remain lower, the sulfated derivatives dominate and may serve as a reservoir, potentially deconjugating target tissues to release the active aglycone. This dynamic underscores the importance of regular dietary flavanol intake to maintain these beneficial metabolites.

Beyond vascular effects, epicatechin improves bone mechanical properties and stimulates type I collagen synthesis. Its microbial metabolite DHPV inhibits matrix metalloproteinases (MMP-1, MMP-2)—enzymes responsible for collagen breakdown—thus preserving cartilage and dermal ECM. This action translates to photoaging protection and joint integrity.

The sources of DHPV are as delicious as they are accessible. A cup of green or black tea, a square of dark chocolate, a glass of red wine, or a supplement containing grape seed extract can all contribute to the production of phenyl-γ-valerolactones via gut fermentation. These foods not only offer sensory pleasure but also deliver a microbial boost with far-reaching health implications.

✅ Grape seed extract/powder is extremely rich in proanthocyanidins (condensed tannins). These are large polyphenols that aren’t absorbed intact but are broken down extensively by gut microbes. The primary metabolites are 5-(3′,4′-dihydroxyphenyl)-γ-valerolactones and their acids (essentially DHPV compounds).

✅ Dark Chocolate (high % cocoa), rich in epicatechin and procyanidins; dual small intestine and colon delivery.

✅ Examples of wines known to have higher procyanidin content include Madiran, Cahors, Cabernet Sauvignon, Sagrantino, Nebbiolo, Monastrell (Mourvèdre), Petit Sirah, and Tannat.

3,4-Dihydroxyphenylacetic Acid (DOPAC), also known as homoprotocatechuic acid, is a microbiota-derived metabolite that forms when gut bacteria process dietary flavonoids, particularly quercetin. This phenylacetic acid has emerged as a significant biologically active compound with remarkable anti-inflammatory properties that work at surprisingly low concentrations.

DOPAC demonstrates effectiveness at just 1-3 µM concentrations, significantly reducing inflammatory markers like TNF-α and IL-6 in laboratory studies. It works by inhibiting NF-κB activation and modulating MAPK pathways, thereby reducing cytokine secretion from immune cells. Beyond inflammation control, DOPAC acts as an antioxidant, scavenging free radicals and protecting cells from oxidative damage, with evidence suggesting it can shield specific cell types like pancreatic β-cells from stress-induced dysfunction.

Human studies confirm DOPAC's presence in the bloodstream after consuming polyphenol-rich foods, with plasma concentrations around or exceeding 1 µM in some cases. Each time you enjoy quercetin-rich foods like onions, apples, or berries, your gut microbes respond hours later by producing DOPAC that helps calm inflammation throughout your body. Unlike nutrients directly consumed in food, DOPAC forms when certain flavonoids reach the colon, where bacteria cleave their rings and degrade them into smaller molecules.

The formation process involves gut microbes breaking down the B-ring of flavonoids containing a 3′,4′-dihydroxy substitution. Specific bacterial species in the genera Clostridium, Eubacterium, and Bacteroides transform these compounds into DOPAC, which is then absorbed into the bloodstream. Research suggests DOPAC may offer neuroprotective properties and contribute to gut health, serving as a key mediator that translates the benefits of flavonoid-rich foods to our tissues. By regularly consuming quercetin-rich products, we enable our bodies to produce this compound that quietly protects our cells against inflammation.

✅ Capers, cloves, and dark chocolate are the highest staple whole food sources for quercetin which could be interesting to reach the microbiome. Even though shallots and red onions are runners-up, these can be eaten in higher amounts. The Japanese pagoda tree (Sophora japonica), especially its flowers has the absolute highest amounts and could function as an extract or supplement. As a health supplement, S. japonica extracts have already been approved for clinical use by the Chinese Pharmacopoeia Commission (2015).

Ellagitannins and ellagic acid are found in a wide range of foods, including pomegranates, berries, walnuts, pecans, red wine, and some medicinal plants. In the digestive tract, ellagitannins are broken down into ellagic acid, which is then further transformed by gut bacteria into a family of compounds known as urolithins—such as urolithin A, B, C, D, and recently discovered G. Specific microbial species like Gordonibacter and Ellagibacter drive this conversion. However, not everyone produces the same set of urolithins; individuals fall into different metabolic types depending on their gut microbiome composition. Some people produce mostly urolithin A, others produce a broader spectrum including urolithin B, and some with a poor microbiome produce very little at all. This variation means that the health effects of ellagitannin-rich foods can differ significantly between individuals.

As ellagitannins are broken down in the body, their antioxidant strength diminishes with each metabolic step. The intact ellagitannins are highly hydroxylated, giving them strong radical-scavenging power. When these are hydrolyzed in the gut into ellagic acid, the antioxidant potential remains high, but absorption is limited. Further conversion by gut microbes produces urolithins—simpler molecules with fewer hydroxyl groups. While urolithins are more bioavailable and can circulate systemically, their direct antioxidant capacity is markedly lower than that of ellagitannins or ellagic acid. Thus, the metabolic pathway favors bioavailability over potency, trading chemical reactivity for tissue access and duration of action. As urolithins become simpler and more bioavailable, their intrinsic antioxidant power decreases, but their indirect effects and tissue accessibility increase.

The narrow scientific focus on Urolithin A (UA) stems from its high bioavailability, consistent appearance in plasma, and well-characterized effects on mitochondrial function, particularly mitophagy. It is the most stable and measurable of the urolithins, making it ideal for clinical trials and patentability—hence its use in products like Mitopure® (don’t use this). However, this narrow commercial focus may overlook the broader metabolic landscape: other urolithins (B, C, M5) and upstream microbial metabolites may offer complementary or synergistic effects, especially in the gut. Whole-food ellagitannin sources support this full-spectrum metabolism, aligning with inter-individual microbiome variability and offering more comprehensive and durable health effects over time.

Ellagitannins, which are found in foods like pomegranates, berries, walnuts, chestnuts, and oak-aged wines, are broken down in the gut into ellagic acid, which is then converted by certain microbes into urolithins. These compounds—including urolithins A, B, and others—don’t just act as antioxidants themselves; they activate the body's defense systems. This includes the Nrf2 pathway, which boosts the production of detoxifying enzymes, and mitophagy, which clears damaged mitochondria and supports cellular energy efficiency. Urolithins also reduce oxidative stress markers, dampen inflammatory signaling via NF-κB, and help maintain mitochondrial function under pressure.

What makes these metabolites especially relevant is their pharmacokinetics. Unlike many polyphenols that pass through the body quickly, urolithins—once formed—can persist in the bloodstream for up to 72 hours. Peak plasma concentrations are typically reached 6–8 hours after intake, reflecting their colonic origin, and even modest levels (1–5 µM) can produce cellular effects such as preserving mitochondrial integrity and boosting glutathione.

Urolithins attenuate cartilage degradation and mitochondrial dysfunction in chondrocytes, reducing IL-6 and COX-2 expression. This suggests its potential as a slow-acting joint protective agent, especially in inflammatory settings like osteoarthritis.

Because microbial conversion is slow and extended, distributing intake throughout the day makes a difference. A dose in the morning initiates fermentation, with effects peaking by afternoon. A second intake at lunch extends urolithin presence into the evening, and an evening dose ensures overnight production. This staggered intake strategy maintains a low-fluctuation baseline of active metabolites in circulation, helping to reinforce antioxidant and mitochondrial support around the clock.

✅ Consume whole foods rich in EAE that can enrich the microbiome with the precursors and producer populations like walnuts and chestnuts. Raspberries have exceptional fiber content among all modern foods and are high in EAE, these are the most potent source for Urolithin production. Food extracts from pomegranate peel and oak wood can be suitable supplements. Yellow raspberries have off-the-chart EAE content. Wines high in tannin.

✅ Walnuts or even the green outer husk of walnuts are highly enriched in ellagitannins and gallotannins. This is similar to pomegranate rind or oak bark in polyphenol profile. If ingested (usually as a powdered supplement or extract, since raw hull is not typically eaten), those ellagitannins release ellagic acid, which gut microbes can convert to urolithin A (and other urolithins). Chestnuts also.

✅ Red ales could be a mid-tier contributor, aged for six months to two years in large oak barrels. While often appreciated for its complex sour-sweet taste, it also delivers distinct biochemical features that align with polyphenol-based health strategies. Through extended contact with oak wood, the beer acquires ellagitannins— These polyphenols are metabolized in the colon by gut bacteria into urolithins. Choose one with mixed fermentation (lactic acid bacteria and wild yeasts) which may also support a more prebiotic-friendly environment, facilitating microbial metabolism of polyphenols. Long-term aging in oak further breaks down polyphenolic structures into forms that are more accessible to gut bacteria, mimicking the kind of slow-release polyphenol conversion seen in more medicinal extracts like Robuvit (oak bark extracts are an option).

Like hippuric acid, 3-Hydroxyphenylacetic Acid (3-HPAA) is a gut microbial overflow metabolite derived from high dietary polyphenol intake, but now especially from those found in foods like cocoa, tea, and grapes. While less potent than other phenolic acids, it accumulates in the colon at concentrations high enough (often exceeding 100 µM) to exert local anti-inflammatory effects, such as modulating immune cells or inhibiting pathways like NF-κB. These effects are likely confined to the gut lumen, as systemic levels in the blood remain low. 3-HPAA’s role includes shaping the microbiome by serving as a substrate or inhibitor for specific bacteria and interacting with colonic receptors like AhR, potentially strengthening the gut barrier.

Hydroxytyrosol (HT) is a small phenolic alcohol (a C6–C2 structure, often classified as a phenylethanoid) famously abundant in olives and extra virgin olive oil. In pure form, it's 3,4-dihydroxyphenylethanol – essentially a catechol ring with a two-carbon side chain. This simple structure belies powerful activity. Hydroxytyrosol is highly bioavailable: after ingestion, it's absorbed rapidly and peaks in plasma within 30–60 minutes. Most HT circulates as phase II conjugates (sulfates and glucuronides) plus minor metabolites like 3,4-dihydroxyphenylacetic acid (DOPAC). Even so, it doesn't require high free concentrations to be effective. A single ~5 mg dose (e.g. from ~20–25 g of extra virgin olive oil) yields low micromolar levels of total hydroxytyrosol metabolites in plasma and is enough to produce biological effects.

One hallmark mechanism of HT is the protection of LDL from oxidation – it's such a potent antioxidant in lipophilic environments that the European Food Safety Authority approved a health claim for olive polyphenols on this basis. In a human trial, ~5.25 mg of hydroxytyrosol given in a food matrix significantly lowered oxidized LDL levels post-meal. Mechanistically, hydroxytyrosol's catechol structure allows it to directly neutralize free radicals and break lipid peroxidation chain reactions, thus safeguarding cell membranes and circulating lipids. It may also support endothelial function by increasing nitric oxide bioavailability (through reduced oxidative stress) and exerting anti-inflammatory effects (e.g. inhibiting NF-κB activation in vascular cells, as observed in some in vitro studies).

The primary targets of hydroxytyrosol are the cardiovascular system and metabolic tissues. It works in the bloodstream (preventing LDL oxidation and DNA oxidative damage) and likely in arteries (improving endothelial responses). Its metabolites have been detected in many organs, suggesting system-wide antioxidant coverage. There's also emerging evidence that hydroxytyrosol could be neuroprotective and renoprotective, owing to its ability to activate cellular antioxidant enzymes (via Nrf2 pathways) and suppress inflammation – though its foremost reputation is heart health.

While preformed HT (I hate when they abbreviate stuff, now the reader has to go look up the name again, why do this? Even AI does this, it’s so lazy…) [hydroxytyrosol] provides a faster and more predictable rise in plasma levels, non-preformed sources (like oleuropein) may offer sustained release or complementary effects, such as broader anti-inflammatory activity and slower metabolic conversion. Combining both types ensures coverage of acute and longer-term antioxidant and vascular effects.

For direct hydroxytyrosol.

✅ Extra virgin olive oil (EVOO) — ~5 mg HT [hydroxytyrosol] per 20–25 g (1.5–2 tbsp); best-validated source. Cold-pressed, early-harvest oils—especially from cultivars like Koroneiki (Greece) or Picual (Spain)—are especially rich.

For nondirect hydroxytyrosol.

✅ Olive leaf powder (tea) or extract – Olive leaves contain even more oleuropein, which is metabolized in vivo to hydroxytyrosol. Olive pit or pomace powder — contains bound polyphenols (including oleuropein derivatives).

Both compounds, stimulate osteoblast activity and decrease osteoclast formation via downregulation of NF-κB and inflammatory cytokines like IL-1β. Oleuropein also prevents bone loss in ovariectomized models, mimicking postmenopausal osteoporosis, and enhances collagen matrix structure.

Current evidence suggests that enterolactone exhibits multifaceted biological activities, including estrogen receptor modulation, anti-proliferative effects on cancer cells, and cardiometabolic risk reduction.

Enterolactone is an enterolignan (a lignan-derived metabolite) produced by gut microbes when we consume lignan-rich foods. Chemically it originates from the dimerization of two C6-C3 units (phenylpropanoids), giving a distinctive diphenolic lignan structure (often depicted as a dihydrobenzofuran skeleton). After eating high-lignan foods like flax or sesame seeds, intestinal bacteria convert precursors (e.g. secoisolariciresinol diglucoside) into enterodiol and enterolactone.

Plasma concentrations of enterolactone are relatively low – typically peaking in the tens of nanomolar range. Enterohepatic recirculation contributes to its prolonged half-life (~12–24 hours), enabling sustained biological activity despite low absolute concentrations. For example, a 0.9 mg/kg dose of flax lignan led to a peak of ~56 nmol/L enterolactone at ~20 hours post-ingestion, and average levels in habitual diets (e.g. in Western populations) are around 30 nM.

Despite these modest levels, enterolactone is biologically active as a weak estrogenic modulator: it can bind estrogen receptors with low affinity, mimicking or subtly blocking estrogen's effects. This phytoestrogen activity helps modulate hormonal pathways – potentially beneficial in hormone-associated conditions (e.g. breast or prostate health, menopausal symptoms, bone density).

✅ Flaxseeds provide the highest lignan content (0.3–0.4 g SDG/100 g), followed by sesame seeds (0.2 g). Sesame seeds are a shared staple food in every so-called Longevity Blue Zone.

Apigenin (4′,5,7-trihydroxyflavone) is a flavonoid in the flavone subclass, featuring the classic C6–C3–C6 flavone backbone. It is widely present in herbs and plant foods (notably parsley, celery, chamomile, and some leafy greens) primarily as glycosides (like apiin in parsley). Apigenin itself is somewhat poorly absorbed – it has low water solubility and gut absorption and undergoes rapid metabolism. Even with a very high intake (e.g. >100 mg from an unusually large parsley serving), peak plasma levels of free apigenin were only on the order of ~0.13 μM in one study. Typically, apigenin appears in plasma mostly as glucuronide and sulfate conjugates within a few hours and is cleared by ~24 hours.

Despite this low bioavailability, apigenin is a valuable "phase 2" addition because it is potent at the target sites and can act in tissues before being fully cleared. Apigenin's known mechanisms include broad anti-inflammatory and cell-regulatory actions. It inhibits pro-inflammatory transcription factors (like NF-κB) and enzymes (like COX-2) in activated immune cells at micromolar concentrations, thereby damping chronic inflammation. It also shows anti-proliferative effects on cancer cells by modulating cell cycle regulators and kinase signaling pathways. Notably, apigenin readily crosses the blood-brain barrier and exerts neuroprotective effects. It has been shown to bind to benzodiazepine sites on GABA_A receptors in the brain, acting as a mild anxiolytic – this is one reason chamomile tea (rich in apigenin) is known for its calming, anti-anxiety effects.

Apigenin promotes neuronal differentiation, encouraging new neuron and synapse formation, suggesting benefits for cognitive function and protection against neurodegeneration. In peripheral tissues, it provides organ protection - reducing oxidative stress and inflammation in kidneys via the Nrf2/HO-1 pathway, shielding renal cells from high-glucose or chemical stress. Similar protective effects extend to the liver and lungs in various injury models. Hormonally, apigenin exhibits mild phytoestrogen activity by selectively binding estrogen receptors and can inhibit aromatase at higher concentrations (IC₅₀ ~20 μM), though this effect may be limited in vivo.

✅ For dietary sources, parsley and celery leaves are exceptionally rich (parsley contains ~300-450 mg/kg apigenin glycosides). Even a small serving (e.g. 5–10 g chopped parsley) provides a notable dose of apigenin precursors, no tea required.

Chrysin (5,7-dihydroxyflavone) is another flavone structurally similar to apigenin but lacking the 4′-hydroxyl on the B-ring. This slight difference gives chrysin unique properties. It is found in nature in modest amounts, most famously in bee propolis (the resinous material collected by bees), as well as in honey (especially from wild flora), passionflower (Passiflora) petals, and some mushrooms. Chrysin's bioavailability is notably poor – under 1% of an oral dose may reach circulation as free chrysin due to its low solubility and extensive gut metabolism. Nonetheless, even low exposure to chrysin can be useful because it's quite potent biochemically.

Chrysin is best known as a natural aromatase inhibitor. Aromatase (CYP19) is the enzyme that converts androgens to estrogens; chrysin can bind to the enzyme's active site and inhibit it. In vitro studies show IC₅₀ values in the low micromolar range (around 1–5 μM) for aromatase inhibition, indicating that at concentrations potentially achievable in tissues (or with higher local accumulation), chrysin could significantly reduce estrogen synthesis. This hints at benefits for hormonal balance – for example, men aiming to maintain a higher testosterone-to-estrogen ratio or postmenopausal women concerned with excess local estrogen in tissues. (It should be noted that human trials with oral chrysin supplements have had mixed results due to its limited absorption; however, as part of a whole-food diet, its effects might be subtle but additive.)

Beyond hormone modulation, chrysin shares many anti-inflammatory and antioxidant actions common to flavonoids. Intriguingly, like apigenin, chrysin has been reported to exhibit anxiolytic (anti-anxiety) effects in animal studies – in mice, chrysin showed benzodiazepine-like activity (via GABA_A receptors) leading to reduced anxiety without sedation. This suggests a potential neuro-calming role, though again bioavailability to the brain is the limiting factor. Chrysin may also protect neurons and other cells by upregulating antioxidant enzymes.

✅ Propolis is by far the richest and most consistent source, often consumed as tinctures or mixed with honey. (propolis extracts often contain 20–30% flavones like chrysin and galangin). Honey, particularly raw and unprocessed varieties, contains chrysin at concentrations up to 5.3 mg per kilogram. Passionflower (Passiflora incarnata) is the runner-up, traditionally used for anxiety and insomnia, partly attributed to chrysin content.

Urolithin A, DHPV, and similar microbial metabolites rely on consistent exposure to dietary polyphenols (like ellagitannins or flavan-3-ols) to maintain their production. Because their presence in plasma reflects microbial fermentation, regular intake (daily or near-daily) is more effective than sporadic consumption. Also, metabolic synergy is real—DHPV often circulates alongside other valerolactones and phase II conjugates that likely act together in antioxidant and anti-inflammatory pathways.

The intricate link between dietary polyphenols and appetite regulation stems from ancient biological systems. Bitter taste receptors (TAS2R), initially evolved in jawless fish over 500 million years ago for toxin detection, were later repurposed in gut cells to sense plant compounds like polyphenols. This allowed early organisms to extract energy while avoiding poisons.

Primates significantly refined these mechanisms 25-40 million years ago as they shifted to fruit-based diets. A co-evolution occurred where polyphenol-rich fruits, attracted primates for seed dispersal, while primates evolved enhanced bitter receptors and gut hormone systems (GLP-1, PYY) sensitive to polyphenol metabolites, in fruits, seeds, leaves, and barks, rewarding consumption with satiety. Hominids inherited this framework, evidenced by ancient gut microbe genes for polyphenol metabolism and Neanderthal diets.

Gut bacteria are crucial partners, with microbes like Bifidobacterium developing polyphenol-processing abilities over 150 million years. Their fermentation of polyphenols in the colon produces beneficial short-chain fatty acids (SCFAs) and smaller phenolic metabolites. These microbial products activate ancient nutrient-sensing pathways, stimulating specialized gut cells (L-cells) via receptors like FFAR2/3 to release satiety hormones GLP-1 and PYY. Modern humans carry this legacy. When we consume polyphenol-rich foods, these compounds often reach the colon undigested. Gut microbiota ferments them, generating SCFAs and other metabolites that signal fullness to the brain. Beyond the colon, polyphenols influence appetite hormones throughout the digestive system by:

1. Boosting satiety hormones (GLP-1, PYY, CCK).

2. Suppressing the hunger hormone ghrelin.

3. Directly activating receptors via their bitter taste.

4. Potentially preventing the breakdown of hormones like GLP-1, extending their effect.

This complex interplay, shaped by evolution from ancient fish to Pleistocene humans adapting to cooked foods, results in polyphenols acting as dietary satiety triggers, contributing to appetite control and metabolic balance.

✅ Research shows that grape pomace supplementation (powder) can strongly influence gut hormones, increasing levels of satiety hormones (GLP-1, PYY, and CCK) while lowering hunger hormone ghrelin. This occurs through both direct actions of grape polyphenols on gut cells and their fermentation by gut microbes.

✅ Chestnuts contain a high complex carbohydrate and fiber content combined with modest fat levels while contributing tannins and other polyphenols like gallic and ellagic acids. What makes chestnuts special is their slow digestion profile - their resistant starch and fiber resist early breakdown and reach the colon, where gut microbes ferment them into short-chain fatty acids (SCFAs) which stimulate GLP-1 and PYY hormone release, contributing to prolonged feelings of fullness.

✅ Kombucha tea has polyphenols and acids that influence gut microbiota, increasing SCFA production (like propionate) which triggers GLP-1 and PYY release. Fermentation also supports beneficial microbes, such as Akkermansia muciniphila (associated with better gut health and satiety), enhancing the overall effect on fullness and the gut environment.

While most polyphenol research centers on cardiovascular and neuroprotective effects, several compounds have demonstrated direct roles in skeletal and connective tissue integrity. These effects span osteoblast activation, osteoclast inhibition, collagen matrix preservation, and anti-inflammatory joint modulation—core functions of ECM and bone homeostasis.

Japanese knotweed (Fallopia japonica) is one of the richest natural sources of preformed polydatin (4)(5), a glucosylated form of resveratrol often referred to as “white resveratrol.” Unlike resveratrol, which is quickly metabolized and eliminated, polydatin is more stable and water-soluble, resulting in improved absorption and tissue delivery.

In the context of bone and joint health, polydatin has been shown to stimulate osteoblast activity and bone formation via BMP2 and Wnt signaling, while inhibiting osteoclast differentiation through suppression of inflammatory pathways like RANKL-NF-κB. Animal models of osteoporosis and osteoarthritis show preserved bone density and cartilage integrity following oral administration of polydatin-rich extracts. Unlike isolated supplements, whole knotweed extracts retain the natural entourage of synergistic compounds found in the plant, potentially enhancing efficacy and safety. Given its traditional use and consistent bioactivity, Japanese knotweed powder or standardized extract offers a practical and food-compatible option to support extracellular matrix integrity and skeletal health—without relying on purified polydatin supplements.

✅ Supplement with Japanese knotweed

Hesperidin, a citrus flavanone glycoside abundant in orange and bitter orange peels, shows strong potential for supporting bone and extracellular matrix (ECM) health. Upon ingestion, hesperidin is converted into its aglycone form, hesperetin, which promotes osteoblast activity and suppresses osteoclast differentiation by downregulating RANKL signaling. These mechanisms translate into dual benefits—stimulating bone formation while reducing bone resorption. In animal studies, hesperidin intake improved bone mineral density, trabecular structure, and mechanical strength. Beyond the skeleton, hesperetin also inhibits matrix metalloproteinases (MMP-2, MMP-9), enzymes involved in collagen and elastin degradation, while promoting ECM-related gene expression—suggesting protective roles in joint, vascular, and connective tissue integrity.

Despite lower systemic bioavailability than flavan-3-ols or phenolic acids, citrus flavanones remain relevant due to their direct antioxidant, metabolic, and vascular actions. After ingestion, compounds like hesperidin, naringin, and eriocitrin undergo phase II conjugation and microbial breakdown into bioactive phenolic acids. These metabolites modulate nitric oxide signaling, reduce oxidative stress, and attenuate inflammation through NF-κB inhibition. Clinical and preclinical studies report improved endothelial function, lipid profiles, and insulin sensitivity, especially when citrus flavanones are consumed regularly as part of the diet.

Lemon peel stands out among citrus sources. It contains high levels of eriocitrin—more water-soluble and potentially better absorbed than hesperidin—as well as d-limonene and other monoterpenes with known anti-inflammatory and chemopreventive properties. While orange and bitter orange peels offer higher hesperidin concentrations, lemon peel offers a broader spectrum of bioactive compounds, making it a practical and potent contributor to a citrus-based polyphenol routine. Other useful sources include grapefruit and bergamot peel (rich in naringin and neoeriocitrin) and concentrated citrus peel powders or whole citrus extracts.

✅ For hesperidin: organic bitter or sweet orange peel (Citrus aurantium). For eriocitrin and others, lemon peel, which is more powerful than limes. Naringin comes from grapefruit or pomelo. Bergamot (Citrus bergamia), often sold as extracts contains structurally related compounds neohesperidin & neoeriocitrin and rare statin-like flavanone glycosides brutieridin & melitidin, why it is often prescribed for cardiovascular and metabolic health.

APPENDIX

While it would be worthwhile to review the range of studies supporting our top-tier polyphenol-rich foods, space constraints make that unfeasible here. One illustrative example, however, comes from a 2022 randomized controlled trial (6) comparing three groups: participants consuming a healthy diet alone, a healthy diet supplemented with walnuts, and another supplemented with green tea. The key outcome was hippocampal occupancy score (HOC), a metric reflecting brain shrinkage associated with aging. Interestingly, the healthy diet by itself did not affect HOC, whereas both the walnut and green tea groups showed reduced brain shrinkage. This reinforces the notion that specific polyphenols—such as those found in walnuts and green tea—not only enter systemic circulation but can also cross the blood-brain barrier, potentially supporting brain structure and cognitive health.

I’m sure that this will be one of the more powerful updates to the BIOS diet when implemented.

APPENDIX

On BIOS, alcohol use is endorsed. Take note of high polyphenol options.

Valerolactones → Red wine (high-procyanidin varieties), cider. Urolithins → Oak-aged red wine, red ales, cognac, nocino. Hydroxycinnamic acids → DHCA/DHFA → Coffee liquors, cider, Amaro. PCA / PGASour → cherry beers, dark fruit wines, red ales. Vanillic acid → Balsamic vinegar, oak-aged spirits, vermouth. Citrus flavanones → Vermouth, bitters (containing peel).

(1) Williamson, G., & Clifford, M. N. (2024). A critical examination of human data for the biological activity of phenolic acids and their phase-2 conjugates derived from dietary (poly) phenols, phenylalanine, tyrosine and catecholamines. Critical Reviews in Food Science and Nutrition, 1-60.

(2) Zheng, J., Xiong, H., Li, Q., He, L., Weng, H., Ling, W., & Wang, D. (2019). Protocatechuic acid from chicory is bioavailable and undergoes partial glucuronidation and sulfation in healthy humans. Food Science & Nutrition, 7(9), 3071-3080.

(3) Mao, Y., Huang, J., Li, S., Chen, G., Du, Y., Kang, M., Zhu, S., Zhang, W., Xu, Q., Wang, Y., Ling, W., Luo, X., & Wang, D. (2025). Brussels chicory enhances exhaustive aerobic exercise performance and post-exercise recovery, possibly through promotion of lactate oxidation: A pilot randomized, single-blind, placebo-controlled, two-way crossover study. Nutrients, 17(365).

(4) Karami, A., Fakhri, S., Kooshki, L., & Khan, H. (2022). Polydatin: pharmacological mechanisms, therapeutic targets, biological activities, and health benefits. Molecules, 27(19), 6474.

(5) Sun, Q., Nan, X. Y., Wang, H., Pan, S., Ji, G., Guo, Y. F., ... & Liu, G. B. (2025). Polydatin retards the progression of osteoarthritis by maintaining bone metabolicbalance and inhibiting macrophage polarization. Frontiers in Bioengineering and Biotechnology, 12, 1514483.

(6) Kaplan, A., Zelicha, H., Meir, A. Y., Rinott, E., Tsaban, G., Levakov, G., ... & Shai, I. (2022). The effect of a high-polyphenol Mediterranean diet (Green-MED) combined with physical activity on age-related brain atrophy: the Dietary Intervention Randomized Controlled Trial Polyphenols Unprocessed Study (DIRECT PLUS). The American Journal of Clinical Nutrition, 115(5), 1270-1281.